The question of whether impaired glucose tolerance (IGT) is relevant to cardiovascular disease, is a subset of the more general question of whether glucose levels are related to cardiovascular disease in non-diabetic subjects. The World Health Organization (WHO) criteria for IGT are a plasma glucose level less than 7.8 mmol and a 2-h post glucose load (75 g) value of 7.8-10.9 mmol [1].
Variability of IGTOne problem with IGT is the variability of the oral glucose tolerance test [2]. Subjects who have had IGT at one examination and have been retested within 3 months changed their classification status in up to 75 % of cases [3]. The concept of IGT has been challenged by Yudkin et al. [4] and Stern et al. [5]. In the latter commentary, it was suggested that the category IGT comprised three groups: a) stable persistent IGT; b) subjects who have IGT but are undergoing rapid conversion to non-insulin-dependent diabetes (NIDDM); and c) subjects who actually had normal glucose tolerance (NGT) but on that particular day had high glucose levels and were placed in the IGT category. In low-risk populations for NIDDM such as Europeans, the number of individuals with IGT in the third category would be particularly high. Given the possible problems with the category of IGT, it might seem surprising that IGT is a risk factor for anything, even for diabetes. However, in recent data from six populations (which include both high and low-risk populations for NIDDM), Edelstein et al. [6] have shown that IGT is a consistent predictor of NIDDM.
IGT and cardiovascular factorsMany studies have shown that IGT is associated with increased cardiovascular risk factors. Burchfiel et al. [7] found that subjects with IGT had increased cardiovascular risk factors (decreased high density lipoprotein (HDL) cholesterol and increased triglyceride, blood pressure, and plasma insulin) intermediate between subjects with NGT and NIDDM. In a study of elderly subjects, Mykkä nen et al. [8] found that men and women with IGT had significantly higher total triglycerides, apolipoprotein B (apo B) and lower HDL cholesterol and apo A than men and women with NGT. In addition, women with IGT had significantly higher systolic blood pressure than women with NGT.
Prevalence of coronary heart disease (CHD) in IGT subjectsIn elderly Finnish subjects [9], the prevalence of definite or probable myocardial infarction was not significantly different in either men or women with IGT compared to subjects with NGT. However, the prevalence of angina was higher in men with IGT than in men with NGT. No differences were seen in the prevalence of angina between women with NGT or IGT. In the San Luis Valley Study [10], the prevalence of overall CHD was increased approximately twofold in both non-Hispanic white men and women with IGT compared to subjects with NGT. However, the prevalence of overall CHD was very similar in Hispanic men and women with IGT and NGT.